Download presentation
Presentation is loading. Please wait.
Published byAsk Klausen Modified over 5 years ago
1
Transcriptional regulators in hepatocarcinogenesis – Key integrators of malignant transformation
Mona Malz, Federico Pinna, Peter Schirmacher, Kai Breuhahn Journal of Hepatology Volume 57, Issue 1, Pages (July 2012) DOI: /j.jhep Copyright © 2012 European Association for the Study of the Liver Terms and Conditions
2
Fig. 1 Modes of dysregulation of transcriptional regulators (TR) in human HCC cells (red) including mutations of upstream signalling pathway components (e.g., receptors and pathway constituents), mutations, and genomic alterations. Possibilities of pathway interference (blue) include the inhibition of receptor tyrosine kinase (RTK) inhibitors, expression of pathway antagonists, and inhibitors of TR-dimerization and TR/DNA interaction. Virotherapy links TRs activity with viral replication and oncolysis. Journal of Hepatology , DOI: ( /j.jhep ) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions
3
Journal of Hepatology 2012 57, 186-195DOI: (10. 1016/j. jhep. 2011. 11
Copyright © 2012 European Association for the Study of the Liver Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.